The Cost-Effectiveness of Directly Observed Highly-Active Antiretroviral Therapy in the Third Trimester in HIV-Infected Pregnant Women
Caitlin J. McCabe, Sue J. Goldie, David N. Fisman · 2010
Read The Cost-Effectiveness of Directly Observed Highly-Active Antiretroviral Therapy in the Third Trimester in HIV-Infected Pregnant Women by Caitlin J. McCabe, Sue J. Goldie, David N. Fisman (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010154.txt.
Description
Caitlin McCabe, Sue Goldie, and David Fisman weighed a treatment plan for pregnant women with HIV in 2010. Suppressing the virus in late pregnancy prevents transmission to the baby. Directly observed therapy, where staff watch each dose, improves that suppression. Their PLOS ONE study projected both effectiveness and cost for the third trimester.
Cost-effectiveness analysis asks whether the health gained is worth the money spent. Watched therapy costs more to deliver than handing over pills. If it prevents enough infant infections, it may be the better buy. Their model was built to make that judgment for health systems.
Catalog record
| CREATOR | Caitlin J. McCabe, Sue J. Goldie, David N. Fisman |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010154